daewoong ipf cs pharma british
Scope
Date
~
-
Arts
Corporate sponsors focus on luxury at Seoul's first Frieze Art Fair
With just three days before the world-renowned Frieze Art Fair launches its inaugural event in Seoul, corporate sponsors are duking it out to outs...
Aug 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota approved for sale in Saudi Arabia, Ukraine
South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukrai...
May 19, 2022 (Gmt+09:00)
-
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung takes 'health is wealth' to whole new level – space
South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...
Apr 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Medytox files complaint with ITC against Hugel over botox strain
South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...
Apr 01, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korea Hana teams up with British developer Nick Candy in Chelsea bid
South Korea’s Hana Financial Group has joined the race to buy English Premier League club Chelsea in a consortium with British property develo...
Mar 20, 2022 (Gmt+09:00)
-
Pharmaceuticals
Samsung Bioepis to double biosimilars, may resume Nasdaq listing plans
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...
Feb 24, 2022 (Gmt+09:00)
-
Pharmaceuticals
Korean pharma joins global race in RNA therapeutics development
The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....
Jan 21, 2022 (Gmt+09:00)
-
Pharmaceuticals
ABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
-
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
Batteries
SKC to invest $33 mn in British battery materials startup Nexeon
South Korea’s SKC Co. is set to invest $33 million in Nexeon Ltd., a British battery materials maker, for the silicon anode materials business...
Nov 01, 2021 (Gmt+09:00)
language -
Batteries
SKC to form JV with British Nexeon for silicon anode business
South Korea’s SKC Co. plans to set up a joint venture with British battery materials maker Nexeon Ltd. for the silicon anode materials market....
Sep 29, 2021 (Gmt+09:00)
-
Private equity
Permira targets growth firms in high valuation markets
London-based private equity firm Permira will maintain its focus on high-quality companies and sector leaders with strong growth potential as valuat...
Sep 03, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Energy
CS Wind buys Portugal's offshore wind energy firm
CS Wind Corp., the global leader in the wind tower market, has agreed to buy a majority stake in Portugal's largest wind tower manufacturer ASM Indu...
Jul 28, 2021 (Gmt+09:00)
language -
ESG
SK, China's Joyvio to launch $90 mn alternative food fund
SK Inc., the investment arm of South Korea's SK Group, will launch a 100 billion won ($90 million) fund jointly with Joyvio Group, a unit of Chinese...
Jul 26, 2021 (Gmt+09:00)
language -
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Energy
CS Wind acquires US wind tower factory from Vestas at $150 mn
South Korea’s wind tower manufacturer CS Wind Corp. has acquired full ownership of the world’s largest tower manufacturing facility loca...
Jun 04, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
Bio
Korea rises as production hub for coronavirus treatments; darling of global pharmas
South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...
Sep 15, 2020 (Gmt+09:00)